NKAPL
NKAP-like protein
Also known as: bA424I5.1, C6orf194, NKAPL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5M9Q1
- Gene
- NKAPL
- Ensembl
- ENSG00000189134
- Chromosome
- 6
- Canonical length
- 402 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
Predicted to enable chromatin binding activity. Predicted to be involved in regulation of gene expression. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
402 residues, UniProt reviewed canonical sequence.
>Q5M9Q1|NKAPL
1 MPPVSRSSYS EDIVGSRRRR RSSSGSPPSP QSRCSSWDGC SRSHSRGREG LRPPWSELDV
61 GALYPFSRSG SRGRLPRFRN YAFASSWSTS YSGYRYHRHC YAEERQSAED YEKEESHRQR
121 RLKERERIGE LGAPEVWGPS PKFPQLDSDE HTPVEDEEEV THQKSSSSDS NSEEHRKKKT
181 SRSRNKKKRK NKSSKRKHRK YSDSDSNSES DTNSDSDDDK KRVKAKKKKK KKKHKTKKKK
241 NKKTKKESSD SSCKDSEEDL SEATWMEQPN VADTMDLIGP EAPIIHTSQD EKPLKYGHAL
301 LPGEGAAMAE YVKAGKRIPR RGEIGLTSEE IGSFECSGYV MSGSRHRRME AVRLRKENQI
361 YSADEKRALA SFNQEERRKR ESKILASFRE MVHKKTKEKD DKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NKAPL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- testis: 30 nTPM
- retina: 12 nTPM
- skeletal muscle: 5.3 nTPM
- heart muscle: 4.7 nTPM
- spinal cord: 3.8 nTPM
- tongue: 3.7 nTPM
Single-cell type
- late primary spermatocytes: 754 nCPM
- early spermatids: 295 nCPM
- early primary spermatocytes: 110 nCPM
- rod photoreceptor cells: 41 nCPM
- undifferentiated spermatogonia: 30 nCPM
- cone photoreceptor cells: 27 nCPM
Immune cell
- plasmacytoid DC: 2.5 nTPM
- neutrophil: 2.2 nTPM
- eosinophil: 1.6 nTPM
- intermediate monocyte: 1.3 nTPM
- memory B-cell: 1.3 nTPM
- classical monocyte: 1 nTPM
Brain region
- pons: 5 nTPM
- white matter: 4.5 nTPM
- cerebral cortex: 4.3 nTPM
- medulla oblongata: 4.2 nTPM
- cerebellum: 4.1 nTPM
- thalamus: 4.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.01
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NKAPL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NKAPL as an antibody target. Whether an autoantibody or antibody against NKAPL could matter depends on whether native NKAPL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NKAPL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NKAPL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...